$3.44 -0.01 (-0.29%) Rigel Pharmaceuticals Inc - NASDAQ

Sep. 23, 2016 | 04:00 PM
Key Statistics
Last Trade: 3.44
Trade Time: Sep 23 04:00 PM Eastern Daylight Time
Change: -0.01 (-0.29%)
Prev Close: 3.45
Open: 3.46
Bid: 3.43
Ask: 3.44

Competitors

Ticker Name Volume % Change
CTLT Catalent 4.13M +0.26%
EXAS EXACT Sciences Corporation 3.54M -6.01%
THLD Threshold Pharmaceuticals Inc. 1.54M -4.10%
PDLI PDL BioPharma Inc. 1.33M +2.39%
NKTR Nektar Therapeutics 1.29M -3.94%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST